Paradox of Bcl‐2 (and p53): why may apoptosis‐regulating proteins be irrelevant to cell death?
- 25 September 2001
- Vol. 23 (10) , 947-953
- https://doi.org/10.1002/bies.1135
Abstract
Although the Bcl‐2 family members and p53 are involved in the regulation of apoptosis, the status of apoptotic machinery (eg caspases) plays a major role in determining the mode and timing of cell death. If the apoptotic machinery is lost, inhibited, or intrinsically inactivated, the “death stars”, Bcl‐2 and p53, may become irrelevant to cell death. In this light, high levels of Bcl‐2 may indicate that downstream apoptotic pathways are still functional. This explains why Bcl‐2 overexpression can be a marker of chemosensitivity and favorable prognosis in certain cancers and why retention of wild‐type p53 may manifest inactivation of caspases in aggressive cancers. BioEssays 23:947–953, 2001. © 2001 John Wiley & Sons, Inc.Keywords
This publication has 66 references indexed in Scilit:
- Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinomaCancer, 2000
- Cell death beyond apoptosisLeukemia, 2000
- Different impact of p53 and p21 on the radiation response of mouse tissuesOncogene, 2000
- Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancerOncogene, 2000
- Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteinsHistopathology, 1998
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell deathOncogene, 1997
- Constitutive expression of the machinery for programmed cell death.The Journal of cell biology, 1996
- Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosisThe Journal of Pathology, 1995
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993